GlassScriptPhysician profile
Zachary Boucher
NPI 1649664616
$18,081.93
in general payments reported to CMS, 2019-2025
14 companies · $2,017 in 2025
The $2,017 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $5,077 · 2021: $7,692 · 2022: $324 · 2023: $1,897 · 2024: $1,076 · 2025: $2,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,138 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Food and Beverage: $875 · Travel and Lodging: $841 · Education: $826 · Gift: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,137.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Food and Beverage | $874.77 |
| Travel and Lodging | $840.92 |
| Education | $825.54 |
| Gift | $310.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asensus Surgical, INC. | $8,367.61 | 2020-2021 | |
| Intuitive Surgical, INC. | $7,647.14 | 2020-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $1,137.50 | 2023 | |
| Tela Bio, INC. | $195.33 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Takeda Pharmaceuticals U.S.A., INC. | $150.00 | 2022 | |
| Davol INC. | $146.96 | 2023 | Phasix Mesh |
| Conmed Corporation | $145.66 | 2020 | |
| Integra Lifesciences Corporation | $114.22 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Polarityte, INC. | $46.98 | 2020 | |
| Abbvie INC. | $46.00 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Baxter Healthcare | $29.49 | 2025 | Coseal, Perclot, Floseal |
| Smith+Nephew, INC. | $23.04 | 2022 | |
| Boston Scientific Corporation | $17.52 | 2023 | Spyglass Discover |
| Ethicon US, LLC | $14.48 | 2025 | Echelon Flex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Boucher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.